SYK 📈 Stryker - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8636671013

SYK: Medical Implants, Surgical Equipment, Patient Care Products, Orthopedic Devices

Stryker Corporation is a medical technology company that operates through two primary segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The company's Orthopaedics and Spine segment is focused on developing and manufacturing implants used in total joint replacements, such as hip, knee, and shoulder surgeries, as well as trauma and extremities procedures. This segment also offers a range of spinal implant products, including cervical and thoracolumbar systems, which are designed to provide fixation, minimally invasive, and interbody solutions for spinal injuries, complex spine conditions, and degenerative therapies. Additionally, the company's Orthopaedics and Spine segment provides a variety of orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation systems, which are used to promote bone growth and repair.

The MedSurg and Neurotechnology segment, on the other hand, offers a broad range of medical devices and equipment, including surgical navigation systems, endoscopic systems, patient handling equipment, emergency medical equipment, and intensive care disposable products. This segment also provides neurosurgical, neurovascular, and craniomaxillofacial implant products, which are used in minimally invasive endovascular procedures, brain and open skull-based surgical procedures, and other complex neurosurgical applications. Furthermore, the company offers a variety of clinical communication and workflow solutions, as well as patient and caregiver safety technologies, which are designed to improve patient outcomes and reduce the risk of adverse events. The MedSurg and Neurotechnology segment also includes reprocessed and remanufactured medical devices, which provide a cost-effective and sustainable alternative to traditional medical devices.

Stryker Corporation sells its products to a global customer base, including doctors, hospitals, and other healthcare facilities, through a network of company-owned subsidiaries and branches, as well as third-party dealers and distributors. The company's products are available in approximately 75 countries, and its global reach is supported by a strong distribution network and a commitment to customer service. With a history dating back to 1941, Stryker Corporation has established itself as a leading player in the medical technology industry, with a reputation for innovation, quality, and customer satisfaction. The company is headquartered in Portage, Michigan, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol SYK.

As a leading medical technology company, Stryker Corporation is committed to developing and manufacturing innovative products that improve patient outcomes and enhance the quality of life. The company's products and services are designed to address a wide range of medical needs, from orthopaedic and spinal implants to neurosurgical and neurovascular devices. With a strong focus on research and development, Stryker Corporation is constantly seeking new and innovative solutions to complex medical problems, and its products and services are used by healthcare professionals around the world to improve patient care and outcomes. The company's website, https://www.stryker.com, provides more information about its products, services, and mission, as well as its financial performance and corporate governance.

Additional Sources for SYK Stock

SYK Stock Overview

Market Cap in USD 142,804m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Equipment
IPO / Inception 1988-02-01

SYK Stock Ratings

Growth 5y 70.9%
Fundamental 50.9%
Dividend 58.1%
Rel. Strength Industry 907
Analysts 4.06/5
Fair Price Momentum 370.08 USD
Fair Price DCF 217.51 USD

SYK Dividends

Dividend Yield 12m 0.88%
Yield on Cost 5y 1.59%
Annual Growth 5y 7.39%
Payout Consistency 95.0%

SYK Growth Ratios

Growth Correlation 3m 66.6%
Growth Correlation 12m 69.8%
Growth Correlation 5y 86%
CAGR 5y 12.60%
CAGR/Mean DD 5y 1.58
Sharpe Ratio 12m 1.00
Alpha -5.83
Beta 1.17
Volatility 22.24%
Current Volume 3146.7k
Average Volume 20d 1266.5k
What is the price of SYK stocks?
As of December 21, 2024, the stock is trading at USD 364.60 with a total of 3,146,693 shares traded.
Over the past week, the price has changed by -4.78%, over one month by -8.11%, over three months by -1.95% and over the past year by +23.49%.
Is Stryker a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Stryker (NYSE:SYK) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 50.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYK as of December 2024 is 370.08. This means that SYK is currently overvalued and has a potential downside of 1.5%.
Is SYK a buy, sell or hold?
Stryker has received a consensus analysts rating of 4.06. Therefor, it is recommend to buy SYK.
  • Strong Buy: 13
  • Buy: 9
  • Hold: 9
  • Sell: 1
  • Strong Sell: 0
What are the forecast for SYK stock price target?
According to ValueRays Forecast Model, SYK Stryker will be worth about 411.3 in December 2025. The stock is currently trading at 364.60. This means that the stock has a potential upside of +12.81%.
Issuer Forecast Upside
Wallstreet Target Price 403.7 10.7%
Analysts Target Price 317.1 -13%
ValueRay Target Price 411.3 12.8%